A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Adverse reactions
- 01 Nov 2017 Status has changed to discontinued.
- 12 May 2009 Lead trial centre and sponsor (Bristol-Myers Squibb), investigators added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.